hers semaglutide shortage Hims & Health: Questions Remain About Compounding Viability Post Resolution of Novo Nordisk halts Wegovy sales

To use information contained herein, please write to our team

PMCID: PMC5551541

Second strongest: patients with type 2 diabetes, where semaglutide or tirzepatide treats both conditions in one prescription

If you have both diabetes and heart disease, this dual benefit makes Ozempic particularly appropriate

Considering the ongoing shortage of injectable incretin-based therapies, future research should aim to prioritize randomized controlled trials evaluating the efficacy of oral semaglutide in patients without diabetes, as well as include a broader demographic spectrum, integrate pharmacological treatment with structured non-pharmacological interventions and improve control over potential confounders, especially those related to lifestyle

Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes